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João E Romão Jr1 and Rosilene M Elias1*Abstract
Background: Urinary density (UD) has been routinely used for decades as a surrogate marker for urine osmolality
(Uosm). We asked if UD can accurately estimate Uosm both in healthy subjects and in different clinical scenarios of
kidney disease.
Methods: UD was assessed by refractometry. Uosm was measured by freezing point depression in spot urines obtained
from healthy volunteers (N = 97) and in 319 inpatients with acute kidney injury (N = 95), primary glomerulophaties
(N = 118) or chronic kidney disease (N = 106).
Results: UD and Uosm correlated in all groups (p < 0.05). However, a wide range of Uosm values was associated
with each UD value. When UD was ≤ 1.010, 28.4% of samples had Uosm above 350 mOsm/kg. Conversely, in 61.6%
of samples with UD above 1.020, Uosm was below 600 mOsm/kg. As expected, Uosm exhibited a strong
relationship with serum creatinine (Screat), whereas a much weaker correlation was found between UD and Screat.
Conclusion: We found that UD is not a substitute for Uosm. Although UD was significantly correlated with Uosm,
the wide dispersion makes it impossible to use UD as a dependable clinical estimate of Uosm. Evaluation of the
renal concentrating ability should be based on direct determination of Uosm.
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Measurement of urine osmolality (Uosm), the gold stand-
ard in the evaluation of urine concentrating ability, is a
valuable tool for the assessment of renal function in such
distinct clinical conditions as acute kidney injury (AKI)
and chronic kidney disease (CKD). However, since Uosm is
not routinely measured, assessment of urine density (UD)
by hydrometry, refractometry or semi-quantitative colori-
metric reactions has long been employed instead.
Although a correlation does exist between UD and Uosm,
at least under normal physiological conditions [1-4], the as-
sumption that UD accurately reflects Uosm, which underlies
any clinical decision based on UD, has not been formally
tested and, in fact, has been recently challenged [5,6].
In the present study we examined the relation between
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unless otherwise stated.subjects as well as in a cohort of 319 patients with assorted
renal disorders, to test the hypothesis that UD can be reli-
ably used in routine clinical practice as a measure of Uosm.Methods
Urine samples were consecutively obtained from 95 adult
patients with AKI in intensive care unit, 118 patients with
primary glomerulopathies, admitted to a Nephrology ward
for investigation, 106 CKD outpatients, and 97 healthy
volunteers. Urine samples were obtained from the first
morning void, with no standardized water restriction. This
study protocol was reviewed and approved by our Institu-
tional Research Ethics Committee (Comissão de Ética para
Análise de Projetos de Pesquisa, CAPPesq, #0045/08). A
written informed consent was obtained.
UD was measured by refractometry, employing a bench-
top refractometer (ATAGO CO.LTD SPR-T2, Tokyo,
Japan). Results were corrected for the influence of protein
and/or glucose according to conventional equations [6]:
UD corrected for proteinuria = UD measured – [protein]This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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[glucose] *0.0002, where both protein and glucose in the
urine are given in g/L. Uosm was measured by freezing
point depression using an advanced wide-range osmom-
eter (Model 3 W2, Advanced Instruments Inc, Needham
Heights, Massachusetts). SCreat was measured with a con-
ventional automated method (enzymatic colorimetric test,
by the Jaffe reaction).
Serum sodium concentration was obtained in 203 pa-
tients (63.3%). Hypernatremia was found in 3 patients
(147 to 149 mEq/l), whereas hyponatremia was observed
in 8 patients (129 to 134 mEq/l). Since dysnatremia was
infrequent, and never severe, this data was not further
analyzed.
AKI was defined according to the current KDIGO clas-
sification [7]. In nearly all patients with glomerulopathies,
hospitalization was indicated for kidney biopsy and/or
clinical management of nephritic or nephrotic syndrome.
Statistical analysis
Univariate correlation analysis between single variables
was performed by calculating the Spearman coefficient.
Data management was performed by Prism 6.0 statistical
software (Graphpad, San Diego, CA, USA). A two-tailed
p value < 0.05 was considered statistically significant.
Results
Spot urine samples from 97 subjects with normal renal
function (Control Group) and from 319 inpatients with
acute kidney injury (AKI, N = 95), glomerulopathies (GP,
N = 118) or chronic kidney disease (CKD, N = 106) were
analyzed.
As expected, UD was consistently correlated to Uosm.
Correlation was statistically significant when all groups
were considered together (r = 0.462, p < 0.0001), as well
as in the healthy control group (r = 0.609, p < 0.0001);
in the AKI group (r = 0.539, p = 0.0008); in the GP group
(r = 0.401, p < 0.0001); and in the CKD group (r = 0.542,
p < 0.0001), as shown in Figure 1A, B, C and D, respect-
ively. UD was corrected for proteinuria and glucosuria as
described under Methods. Proteinuria was found in almost
60% of samples: overall, only 171 out of 416 samples were
free from proteinuria or glucosuria (all 98 healthy volun-
teers, 35 out of 95 in the AKI group, 35 out of 106 in the
CKD group, and only 3 out of 118 in the GP group). Glu-
cosuria was found in only 5 patients from the CKD group
and in 4 patients from the GP group. These 9 samples also
exhibited proteinuria, and therefore both equations
were used for correction. When only urine samples with-
out proteinuria or glucosuria were analyzed, the correl-
ation between UD and Uosm was even stronger (r = 0.572,
p < 0.0001) (Figure 1E).
Despite the significant correlation between UD and
Uosm, a wide range of Uosm values was associated witheach UD value. This inconsistency was particularly strik-
ing when extreme UD values were considered (Figure 2,
shaded areas): 39.8% of samples with UD lower or equal
to 1.010 exhibited Uosm in excess of 350 mOsm/kg. Con-
versely, in 58.6% of samples with UD above 1.020, Uosm
was below 600 mOsm/kg.
Low, normal and high renal concentration ability was
defined as UD lower or equal to 1.010, between 1.010 and
1.020, and above or equal to1.020 kg/L, and Uosm lower
than 350 mOsm/kg, between 350 and 600 mOsm/kg, and
higher than 600 mOsm/kg, respectively. The number of
patients classified in each criterion is plotted in Table 1.
Agreement between UD and Uosm is highlighted in gray.
When analyzing healthy subjects, UD was an excellent
predictor of Uosm when it was above 1.020: 100% of these
samples exhibited Uosm above 600 mOsm/kg. By sharp con-
trast, UD failed to predict Uosm when UD was below or
equal to 1.010: only 29.2% of samples had Uosm lower than
350 mOsm/kg, while Uosm was higher than 600 mOsm/kg
in 37.5% of the samples.
Figure 3A illustrates the relationship between Uosm and
serum creatinine (Screat), for all subjects. Uosm and Screat
followed a nonlinear relationship that could be fitted to a
two-exponential curve (p < 0.01): Uosm was expectedly dis-
tributed across a wide range (118–1245 mOsm/kg) in sub-
jects with Screat lower than 1.0 mg/dL and was confined to
a narrow interval around 300 mOsm/kg as Screat increased.
The relationship between Uosm and Screat was still signifi-
cant (p < 0.05), although much less conspicuous, when UD
replaced Uosm as a measure of urine concentration
(Figure 3B). When analyzing subgroups, the correl-
ation between Uosm and Screat was significant in the AKI
group (r =−0.451, p < 0.001), in the GP group (r =−0.533,
p = 0.0001), and in the CKD group (r = −0.546, p = 0.0001).
There was no significant correlation between Uosm and Screat
in the healthy control group (r =−0.108, p = 0.289). A
weaker but still significant correlation between UD and Screat
was shown in the AKI group (r = −0.160, p = 0.001), in
the GP group (r = −0.253, p = 0.026), and in the CKD
group (r =−0.209, p = 0.031). There was no correlation
between UD and Screat in the healthy control group
(r = −0.102, p = 0.863).
Discussion
Urine density has long been considered as a practical sur-
rogate marker of urine osmolality. It has even been pro-
posed that simple equations be used in clinical practice to
obtain Uosm directly from UD [8-11], whereas a website
offers such calculations online [12]. In the present study,
we challenged the concept that UD is a reliable marker of
urine osmolality. For better accuracy, UD measurements
were made utilizing a refractometer, instead of the semi-
quantitative dipstick method more commonly employed.
Even so, the correlation obtained between UD and Uosm,
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Figure 1 Correlation between urinary osmolality (Uosm) and urinary density (UD) in each subgroup of patients: healthy control (A), acute kidney
injury – AKI (B), glomerulopathies - GP (C), chronic kidney disease – CKD (D), and the entire group with urine free of protein and glucose (E).
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0.462). A closer examination casts serious doubts about
the clinical usefulness of UD. If an UD of 1.020 kg/L or
higher were regarded as a test to detect individuals with
an Uosm of at least 600 mOsm/kg [8-10], the sensitivity of
such a test would be only 36%, whereas its specificity
would be 81%. In other words, 64% of the subjects with
concentrated urines would be missed by such test. On the
other hand, good renal concentration ability might beerroneously inferred in as many as 19% of the other cases.
Conversely, if an UD equal to or less than 1.010 kg/L were
assumed to detect urine osmolalities below 350 mOsm/kg
(isosthenuric or diluted urine), the sensitivity of the test
would be only 40%, although the corresponding specificity
would approach a more acceptable 80%.
The inadequacy of UD as a measure of Uosm becomes
even more evident when we consider that in about 2/3
of all samples UD values were ≥1.010 and ≤1.020 kg/L,
Figure 2 Correlation between urinary osmolality (Uosm) and urinary density (UD) in all groups. Shaded areas are pointing to unexpected
high or low UD while Uosm was the opposite.
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whether or not to administer IV saline to hypovolemic
patients. When only UDs equal or higher than 1.020 kg/
L were analyzed, a mere 41.4% of the samples actually
exhibited Uosm above 600 mOsm/kg, whereas in 29.9%
Uosm was even below 350 mOsm/kg. In the converse case,
when exclusively UDs equal or lower than 1.010 kg/L wereTable 1 Comparison between urinary density (UD) and osmolalit
UD criteria Osmolality criteria
All patients Low (<350mOsm/kg)
Low UD (≤1.010 kg/L) 71
Normal UD (1.011 – 1.019 kg/L) 79
High (UD ≥1.020 kg/L) 26
Patients with AKI
Low UD (≤1.010 kg/L) 28
Normal UD (1.011 – 1.019 kg/L) 20
High (UD ≥1.020 kg/L) 13
Patients with CKD
Low UD (≤1.010 kg/L) 8
Normal UD (1.011 – 1.019 kg/L) 23
High (UD ≥1.020 kg/L) 3
Patients with glomerulonephritis
Low UD (≤1.010 kg/L) 28
Normal UD (1.011 – 1.019 kg/L) 36
High (UD ≥1.020 kg/L) 10
Healthy individuals
Low UD (≤1.010 kg/L) 7
Normal UD (1.011 – 1.019 kg/L) 0
High (UD ≥1.020 kg/L) 0
Bold numbers show agreement between UD and Uosm.
AKI, acute kidney injury; CKD, chronic kidney disease.considered, 60.2% of samples exhibited Uosm values lower
than 350 mOsm/kg, whereas in 16.9% Uosm even exceeded
600 mOsm/kg. These results indicate that UD cannot
replace Uosm as a faithful measurement of urine con-
centration. Although a high Uosm may not reflect the
actual volume status, such as in cases of inappropriate
antidiuretic hormone secretion, in many situations ity (Uosm) classification of low and high concentration ability
Normal (350-600mOsm/kg) High (>600mOsm/kg)
27 20
89 43
25 36
2 0
17 2
11 2
10 10
38 6
5 3
7 1
21 2
9 4
8 9
13 33
0 27
Figure 3 Correlation between serum creatinine (SCreat) levels
and urinary osmolality (Uosm) (A), and urinary density (UD) (B).
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an erroneous interpretation of a high UD as indicative
of hypovolemia may lead to inadequate and even dan-
gerous fluid administration.
As expected, there was a significant nonlinear correl-
ation between Uosm and Screat, reflecting the expected rela-
tionship between renal function and urine concentrating/
diluting ability: individuals with normal renal function can
vary urine osmolality over a wide range, while renal func-
tional impairment is accompanied by a progressive limita-
tion of this capacity, until urine becomes permanently
isosthenuric as most of the renal function is lost. This re-
lationship between Uosm and Screat was strongly attenuated
when UD was used instead of Uosm, reinforcing the view
that UD is a poor marker of renal concentrating/diluting
ability.
The reasons why the relationship between UD and Uosm
is less consistent than might be expected are unclear. In the
present study, the effect of the possible presence of glucose
and/or protein in urine was corrected by applying appropri-
ate equations [6,13]. However, the association between UD
and Uosm remained loose even after samples containing
these solutes were excluded (r = 0.459, p < 0.05). It should
be noted that a myriad of other solutes, commonly encoun-
tered in the urine of patients with renal disorders, such asdrugs and iodinated radiocontrast agents, could in-
crease urine density, leading to overestimation of the
renal concentrating ability. Even “physiologic” solutes,
such as sodium, potassium and urea, can appear in
widely varying proportions in the urine of both healthy
and diseased subjects, each of them exerting a different
influence on urine density [9]. The unpredictability of
these effects helps to explain the erratic relationship
between UD and Uosm.
Conclusion
In summary, although UD correlates with Uosm, the rela-
tionship between these two parameters is largely inconsist-
ent, even in healthy subjects, indicating that UD is a poor
marker of renal concentrating/diluting capability. Direct de-
termination of Uosm, a relatively inexpensive procedure,
should be performed if reliable information about this
important aspect of renal function is to be obtained
from urine.
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